Engineering Ferroptosis Inhibitors as Inhalable Nanomedicines for the Highly Efficient Treatment of Idiopathic Pulmonary Fibrosis

Engineering Ferroptosis Inhibitors as Inhalable Nanomedicines for the Highly Efficient Treatment of Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) refers to chronic progressive fibrotic interstitial pneumonia. It is called a “tumor-like disease” and cannot be cured using existing clinical drugs. Therefore, new treatment options are urgently needed. Studies have proven that ferroptosis is closely related to t...

Full description

Bibliographic Details
Main Authors: Mengqin Guo, Tingting Peng, Chuanbin Wu, Xin Pan, Zhengwei Huang
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Bioengineering
Subjects:
ferroptosis inhibitor
idiopathic pulmonary fibrosis
inhalable
nanomedicine
micelles
liposomes
Online Access:https://www.mdpi.com/2306-5354/10/6/727

Similar Items

Similar Items